EGFR and glioblastoma: Both full-length LRIG2 and LRIG2 ectodomain promoted the proliferation and inhibited the apoptosis of glioblastoma in vitro and in vivo probably through enhancing the EGFR activation and its downstream PI3K/Akt pathway.